brivaracetam vs clonazepam
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of brivaracetam and clonazepam. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Briviact
Klonopin
Brivaracetam is a medicine used to treat partial-onset seizures. It helps to reduce the number of seizures you have.
Clonazepam is a medicine that belongs to the benzodiazepine class. It is used to treat seizure disorders and panic disorder.
Brivaracetam is used to treat partial-onset seizures. These seizures start in one part of the brain. It can be used alone or with other seizure medicines for people 1 month and older.
Clonazepam is used to treat certain seizure disorders, including Lennox-Gastaut syndrome, akinetic, and myoclonic seizures. It can also treat absence seizures when other medicines don't work. Clonazepam also treats panic disorder, which involves unexpected panic attacks and worry about having more attacks.
Brivaracetam binds to a protein in the brain called SV2A. This helps to reduce the electrical activity in the brain that causes seizures. It helps to stabilize nerve cells.
Clonazepam works by affecting chemicals in your brain that may be unbalanced. It enhances the effects of a natural brain chemical called GABA. This helps to reduce seizures and relieve panic symptoms.
- • Feeling sleepy or tired
- • Dizziness
- • Fatigue
- • Nausea or vomiting
- • Drowsiness
- • Problems with coordination
- Seizure 1,810
- Therapy Interrupted 280
- Overdose 233
- Fatigue 230
- Somnolence 216
- Fatigue 10,236
- Nausea 9,564
- Anxiety 8,735
- Headache 8,590
- Depression 8,121
Brivaracetam can cause suicidal thoughts or actions. Watch for new or worsening depression, suicidal thoughts or behavior, or unusual changes in mood. Tell your doctor right away if you have any of these symptoms. Do not stop taking brivaracetam suddenly, as this may increase your risk of seizures.
Taking clonazepam with opioid medicines can cause very serious problems, including slowed breathing, coma, and death. Only take these medicines together if there are no other options. Clonazepam can be habit-forming, leading to abuse, misuse, and addiction, which can result in overdose or death. Stopping clonazepam suddenly can cause dangerous withdrawal symptoms. Your doctor will slowly lower your dose to prevent withdrawal.
Tell your doctor if you are pregnant or plan to become pregnant. There is a pregnancy registry for women who take brivaracetam during pregnancy. Contact the North American Antiepileptic Drug (NAAED) Pregnancy Registry at 1-888-233-2334.
Clonazepam may harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Clonazepam can pass into breast milk and may harm a nursing infant.
Also Compare, Nearby Drugs
Compare clonazepam with
How to Read This brivaracetam vs clonazepam Comparison
brivaracetam is classified in the Anticonvulsant (SV2A Ligand) drug class, while clonazepam sits within the Benzodiazepine class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, brivaracetam has 2,769 submissions while clonazepam has 45,246. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for brivaracetam or clonazepam.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.